Polymyositis

What is polymyositis?

Polymyositis is a rare, long-term inflammatory disease that affects the muscles you use to move your body. The word itself explains the condition: “poly” means many, “myo” means muscle, and “itis” means inflammation. In polymyositis, the body’s immune system — the system that normally protects you from infection — mistakenly attacks healthy muscle tissue. This ongoing inflammation causes the muscles to become weak, and sometimes tender or achy. Because the immune system attacks the body’s own tissues, polymyositis belongs to a group of conditions called autoimmune diseases.

Polymyositis is classified as an idiopathic inflammatory myopathy. “Idiopathic” means the exact cause is not known, and “myopathy” means a disease of the muscle. It is closely related to other conditions in the same family, such as dermatomyositis (which also involves a skin rash) and inclusion body myositis. In medical coding, polymyositis is listed under ICD-10 code M33.2.

The condition most often develops in adults between the ages of 30 and 60, and it appears to affect women more often than men. It is rare in children; when a similar disease occurs in childhood, it is usually a related condition called juvenile dermatomyositis rather than true polymyositis. Polymyositis typically develops gradually over weeks to months, rather than appearing suddenly. Because it is uncommon and its symptoms can resemble many other muscle and nerve disorders, it is usually managed by specialists in rheumatology, a branch of medicine focused on autoimmune and joint-and-muscle diseases, sometimes together with neurologists (nerve and muscle specialists).

Symptoms of polymyositis

The main symptom of polymyositis is muscle weakness that develops slowly and affects both sides of the body in a roughly equal, symmetric pattern. The weakness usually involves the muscles closest to the trunk — doctors call these the proximal muscles — such as the muscles of the hips, thighs, shoulders, upper arms, and neck.

Common polymyositis symptoms include:

• Weakness in the hips and thighs, which may make it hard to climb stairs, rise from a chair, or get out of a car.
• Weakness in the shoulders and upper arms, which can make it difficult to lift objects, reach overhead, or brush your hair.
• Neck weakness, sometimes noticed as difficulty lifting the head off a pillow.
• Muscle aching or tenderness in some people, although many people have weakness without significant pain.
• Fatigue — a persistent feeling of tiredness or lack of energy.
• Difficulty swallowing (called dysphagia) if the muscles of the throat are involved.
• Shortness of breath in some cases, either because breathing muscles are weakened or because the lungs themselves become inflamed.
• Unintended weight loss or low-grade fever in some people, reflecting general inflammation in the body.
• Joint aches without severe swelling, in some cases.

Symptoms often change over time and can differ depending on the stage of the disease. In the early stage, people may notice only mild difficulty with everyday tasks, such as feeling unusually tired after climbing a flight of stairs. As inflammation continues without treatment, the weakness typically becomes more obvious and may spread to affect more muscle groups. In advanced or long-standing disease, muscles may shrink (a process called atrophy), and swallowing or breathing problems can become more serious.

It also helps to know how polymyositis differs from related conditions, because doctors often consider them together. In dermatomyositis, muscle weakness is accompanied by a distinctive skin rash, often on the eyelids, knuckles, chest, or back. In inclusion body myositis, weakness tends to appear later in life, often affects the fingers and the muscles at the front of the thighs, and may be less symmetric. True polymyositis does not include a rash, and this difference is one of the clues doctors use to tell these conditions apart.

Importantly, the small muscles of the hands and feet, the muscles of the face, and the muscles that move the eyes are usually not affected in polymyositis. If a person has prominent weakness in these areas, doctors will usually look carefully for a different diagnosis.

Causes and risk factors

The exact polymyositis causes are not fully understood. What is known is that the immune system plays a central role. In polymyositis, immune cells called T lymphocytes (a type of white blood cell) invade muscle tissue and damage muscle fibers directly. Why the immune system begins to treat muscle as a threat remains unclear, and research is ongoing.

Several factors are thought to contribute to the risk of developing polymyositis:

• Genetic susceptibility. Certain inherited variations in immune-system genes appear to make some people more likely to develop autoimmune muscle disease. Polymyositis itself is not directly inherited, and most relatives of affected people never develop it.
• Age and sex. The condition most often begins between ages 30 and 60 and is more common in women.
• Environmental triggers. In genetically susceptible people, viral infections or other environmental exposures may act as a trigger that sets off the abnormal immune response, although no single virus has been proven to cause polymyositis.
• Other autoimmune diseases. Polymyositis can occur alongside other autoimmune conditions, such as lupus, rheumatoid arthritis, scleroderma, or Sjögren’s syndrome. When muscle inflammation occurs as part of another connective tissue disease, doctors may describe it as an overlap syndrome.
• Certain medications. Some drugs — for example, certain cholesterol-lowering medicines — can cause muscle inflammation that resembles polymyositis. This is one reason doctors carefully review all medications during diagnosis.

It is important to understand that polymyositis is not contagious — you cannot catch it from another person — and it is not caused by anything a person did or failed to do. In some adults, inflammatory muscle disease can be associated with an underlying cancer, so doctors may recommend age-appropriate cancer screening after the diagnosis is made, particularly in older patients. This association is stronger for dermatomyositis than for polymyositis, but screening is still often considered.

Diagnosis

Polymyositis diagnosis can take time, because many other conditions — including thyroid disease, medication side effects, nerve disorders, and inherited muscle diseases — can cause similar weakness. Doctors usually combine several types of evidence before confirming the diagnosis.

The evaluation typically includes:

• Medical history and physical examination. The doctor asks how and when the weakness started, which activities have become difficult, and whether there are swallowing or breathing symptoms. During the examination, the doctor tests the strength of individual muscle groups and looks for the typical pattern of symmetric weakness in the hips, thighs, and shoulders.
• Blood tests for muscle enzymes. When muscle fibers are damaged, they release enzymes (proteins) into the bloodstream. The most commonly measured enzyme is creatine kinase (CK). Levels of CK and related enzymes such as aldolase are usually elevated in active polymyositis.
• Autoantibody tests. Autoantibodies are immune proteins directed against the body’s own tissues. Certain antibodies, called myositis-specific and myositis-associated antibodies, can support the diagnosis and sometimes help predict which organs may be involved.
• Electromyography (EMG). In this test, a thin needle electrode is inserted into a muscle to record its electrical activity. Inflamed muscle produces characteristic abnormal patterns, and EMG also helps rule out nerve diseases that can mimic myositis.
• Magnetic resonance imaging (MRI). An MRI scan can show areas of inflammation and swelling within muscles. It can also help doctors choose the best site for a biopsy.
• Muscle biopsy. A biopsy — the removal of a small sample of muscle tissue, usually under local anesthetic — is often the key test. Under the microscope, polymyositis shows immune cells invading and damaging muscle fibers. The biopsy also helps distinguish polymyositis from dermatomyositis, inclusion body myositis, and non-inflammatory muscle diseases.

Depending on the individual situation, doctors may also order chest imaging and lung function tests to check for lung involvement, swallowing studies if dysphagia is present, and heart tests such as an electrocardiogram, because inflammation can occasionally affect the heart muscle. Classification criteria developed by international rheumatology and myositis research groups combine these findings — the pattern of weakness, enzyme levels, antibodies, EMG results, and biopsy features — to support the diagnosis.

Treatment options for polymyositis

There is currently no known cure for polymyositis, but polymyositis treatment can often control the inflammation, improve strength, and allow many people to return to most of their usual activities. Treatment is usually coordinated by a rheumatologist, sometimes together with neurologists, lung specialists, and rehabilitation therapists. At Acibadem, this condition is managed within the Rheumatology Department, which handles autoimmune muscle and connective tissue diseases.

Because polymyositis is a progressive inflammatory disease, simple watchful waiting is generally not appropriate once the diagnosis is confirmed; untreated inflammation tends to cause further muscle damage. The main treatment approaches are:

• Corticosteroids. Medicines such as prednisone are usually the first treatment. They suppress inflammation broadly and often begin to improve strength over weeks to months. Because long-term corticosteroid use can cause side effects — including weight gain, bone thinning (osteoporosis), high blood sugar, and increased infection risk — doctors aim to reduce the dose gradually to the lowest amount that keeps the disease controlled.
• Steroid-sparing immunosuppressants. Medicines such as methotrexate, azathioprine, or mycophenolate mofetil dampen the overactive immune response and allow the corticosteroid dose to be lowered. These drugs require regular blood tests to monitor for side effects on the liver, blood counts, and other organs.
• Intravenous immunoglobulin (IVIG). This is a preparation of antibodies given through a vein. It may be used when standard medicines do not work well enough, when swallowing muscles are severely affected, or when other drugs cannot be used safely.
• Biologic and other advanced therapies. For disease that does not respond to standard treatment, doctors may consider medicines such as rituximab, which targets specific immune cells. These decisions are individualized and based on the person’s overall health and disease features.
• Physical therapy and rehabilitation. A supervised exercise program is an essential part of treatment. Once inflammation is being controlled, gentle strengthening and stretching exercises help rebuild muscle, protect joints, and prevent stiffness. Speech and swallowing therapy can help people with dysphagia eat and drink safely.
• Supportive care. This may include medicines to protect the bones during corticosteroid treatment, vaccinations as advised by the care team (because immunosuppressive medicines increase infection risk), and treatment of lung or heart involvement if present.

Surgery is not a treatment for polymyositis itself, since the disease affects muscle tissue throughout the body rather than a single area that could be operated on. In rare situations, procedures may be used to manage complications — for example, a feeding tube if swallowing becomes unsafe — but these are supportive measures rather than treatments for the underlying disease.

Response to treatment varies from person to person. Some people improve substantially with corticosteroids alone; others need combinations of medicines over a longer period. Regular follow-up, including strength assessments and blood tests, helps the care team adjust treatment over time.

Living with polymyositis and outlook

Polymyositis is a chronic condition, meaning it usually requires long-term management rather than a one-time treatment. With modern therapy, many people achieve good control of the disease and regain much of their strength, although the course is variable. Some people experience a single episode that responds well to treatment and then stays quiet; others have a relapsing course, with periods of improvement followed by flares; and a smaller group has disease that remains active despite treatment and requires more intensive therapy.

Several practical steps can help with daily life:

• Stay as active as your care team advises. Appropriate, guided exercise helps maintain strength and flexibility without overstraining inflamed muscles.
• Pace yourself. Fatigue is common, and balancing activity with rest can make daily tasks more manageable.
• Take medicines as prescribed. Stopping corticosteroids or immunosuppressants suddenly can trigger a flare or cause other problems; changes should always be made with your doctor.
• Protect your bones and general health. A balanced diet, adequate calcium and vitamin D as advised by your doctor, and not smoking support overall health during long-term treatment.
• Attend regular follow-up visits. Monitoring allows early detection of flares, medication side effects, and complications involving the lungs, heart, or swallowing.
• Seek support. Living with a chronic illness can be emotionally demanding; counseling and patient support groups may help.

Honest prognosis language matters here: outcomes cannot be guaranteed, and some people are left with a degree of lasting weakness even after inflammation is controlled, particularly if treatment started late. Serious complications — such as significant lung involvement, severe swallowing problems, or heart involvement — are possible but affect only a minority of patients. Early diagnosis and consistent treatment generally improve the chances of a good outcome.

Frequently asked questions

What is polymyositis in simple terms?

Polymyositis is an autoimmune disease in which the body’s immune system attacks its own muscles, causing inflammation and weakness. The weakness mainly affects the muscles closest to the trunk — the hips, thighs, shoulders, and neck — on both sides of the body, and it usually develops gradually over weeks to months. It most often affects adults between 30 and 60 years of age.

Can polymyositis be cured?

There is currently no cure for polymyositis, but it can usually be treated. Medicines that calm the immune system, combined with physical therapy, often reduce inflammation and improve strength. Many people achieve long periods with well-controlled disease, and some remain stable for years, but ongoing monitoring is generally needed because the condition can flare again.

How serious is polymyositis?

The seriousness varies widely. Some people have relatively mild weakness that responds well to treatment, while others develop more significant problems, including difficulty swallowing, lung inflammation, or, less commonly, heart involvement. Untreated polymyositis tends to worsen over time, which is why early diagnosis and treatment are important. With appropriate care, many people maintain a good quality of life.

What are the first symptoms of polymyositis?

The earliest polymyositis symptoms are often subtle: difficulty climbing stairs, trouble rising from a low chair, or tiredness when lifting the arms — for example, when washing hair. Muscle aching, general fatigue, and, in some cases, swallowing difficulty may follow. Because the weakness develops slowly, many people initially attribute it to aging or lack of fitness, which can delay diagnosis.

How is polymyositis diagnosed?

Doctors confirm the diagnosis by combining several findings: the typical pattern of symmetric weakness near the trunk, elevated muscle enzymes such as creatine kinase in the blood, specific autoantibody tests, electrical testing of the muscles (EMG), and often MRI scans. A muscle biopsy — examining a small tissue sample under the microscope — is frequently the deciding test, because it shows the characteristic immune-cell damage and rules out similar conditions.

Can you recover strength after polymyositis?

Many people regain a substantial amount of strength once treatment controls the inflammation, especially when therapy starts early and is combined with a guided rehabilitation program. Recovery is usually gradual, over months rather than weeks. However, if muscle damage has been present for a long time before treatment, some weakness may persist even after the inflammation settles.

Is polymyositis the same as dermatomyositis?

No. The two conditions are closely related inflammatory muscle diseases, and both cause weakness in the muscles near the trunk, but dermatomyositis also causes a characteristic skin rash — often on the eyelids, knuckles, chest, or back — while polymyositis does not. The underlying immune mechanisms and biopsy findings also differ, and doctors distinguish between them because monitoring and treatment details can vary.

When to see a doctor

If you notice muscle weakness that develops over weeks or months without a clear explanation — especially difficulty climbing stairs, standing up from a chair, or lifting your arms — it is reasonable to see a doctor for evaluation. Early assessment matters, because inflammatory muscle diseases respond best when treated before significant muscle damage occurs.

Seek medical attention promptly, or emergency care where appropriate, if you experience any of the following red-flag warning signs:

• Difficulty swallowing, choking on food or liquids, or food feeling stuck in the throat — this raises the risk of food or liquid entering the lungs.
• Shortness of breath, a new persistent cough, or breathing that feels weak or shallow.
• Rapidly worsening weakness, such as suddenly being unable to stand, walk, or hold your head up.
• Chest pain, palpitations, or fainting, which could suggest heart involvement and need urgent assessment.
• High fever or signs of infection while taking immune-suppressing medicines, since these drugs reduce the body’s ability to fight infection.
• Dark, tea-colored urine together with severe muscle pain, which can indicate serious muscle breakdown affecting the kidneys.

If you have already been diagnosed with polymyositis, contact your care team whenever your symptoms change noticeably, a flare seems to be starting, or you develop new side effects from your medicines. Regular follow-up with your rheumatology team is an important part of keeping the condition under control.